294 related articles for article (PubMed ID: 28596377)
21. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH
Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806
[TBL] [Abstract][Full Text] [Related]
22. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
Sheu JR; Chao SH; Yen MH; Huang TF
Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
[TBL] [Abstract][Full Text] [Related]
23. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
24. Small molecule targeting the Rac1-NOX2 interaction prevents collagen-related peptide and thrombin-induced reactive oxygen species generation and platelet activation.
Akbar H; Duan X; Piatt R; Saleem S; Davis AK; Tandon NN; Bergmeier W; Zheng Y
J Thromb Haemost; 2018 Oct; 16(10):2083-2096. PubMed ID: 30007118
[TBL] [Abstract][Full Text] [Related]
25. Quercitrin inhibits platelet activation in arterial thrombosis.
Oh TW; Do HJ; Jeon JH; Kim K
Phytomedicine; 2021 Jan; 80():153363. PubMed ID: 33070081
[TBL] [Abstract][Full Text] [Related]
26. Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma -chain in response to the snake venom convulxin but not to collagen.
Zheng YM; Liu C; Chen H; Locke D; Ryan JC; Kahn ML
J Biol Chem; 2001 Apr; 276(16):12999-3006. PubMed ID: 11152687
[TBL] [Abstract][Full Text] [Related]
27. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors.
Clemetson JM; Polgar J; Magnenat E; Wells TN; Clemetson KJ
J Biol Chem; 1999 Oct; 274(41):29019-24. PubMed ID: 10506151
[TBL] [Abstract][Full Text] [Related]
28. Galectin-9 activates platelet ITAM receptors glycoprotein VI and C-type lectin-like receptor-2.
Zhi Z; Jooss NJ; Sun Y; Colicchia M; Slater A; Moran LA; Cheung HYF; Di Y; Rayes J; Poulter NS; Watson SP; Iqbal AJ
J Thromb Haemost; 2022 Apr; 20(4):936-950. PubMed ID: 34936188
[TBL] [Abstract][Full Text] [Related]
29. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis.
Liu CZ; Peng HC; Huang TF
Toxicon; 1995 Oct; 33(10):1289-98. PubMed ID: 8599180
[TBL] [Abstract][Full Text] [Related]
30. Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.
Jeanne A; Sarazin T; Charlé M; Kawecki C; Kauskot A; Hedtke T; Schmelzer CEH; Martiny L; Maurice P; Dedieu S
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e1-e17. PubMed ID: 33232198
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration.
Kojima H; Moroi M; Jung SM; Goto S; Tamura N; Kozuma Y; Suzukawa K; Nagasawa T
J Thromb Haemost; 2006 Nov; 4(11):2433-42. PubMed ID: 17059472
[TBL] [Abstract][Full Text] [Related]
32. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
33. Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation.
Nestele JA; Rohlfing AK; Dicenta V; Bild A; Eißler D; Emschermann F; Kremser M; Krutzke K; Schäffer TE; Borst O; Levi M; Korin N; Gawaz MP
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008437
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI.
Inoue K; Ozaki Y; Satoh K; Wu Y; Yatomi Y; Shin Y; Morita T
Biochem Biophys Res Commun; 1999 Mar; 256(1):114-20. PubMed ID: 10066433
[TBL] [Abstract][Full Text] [Related]
35. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
Hermans C; Wittevrongel C; Thys C; Smethurst PA; Van Geet C; Freson K
J Thromb Haemost; 2009 Aug; 7(8):1356-63. PubMed ID: 19552682
[TBL] [Abstract][Full Text] [Related]
36. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
Wielders SJ; Bennaghmouch A; Reutelingsperger CP; Bevers EM; Lindhout T
J Thromb Haemost; 2007 Mar; 5(3):571-6. PubMed ID: 17166251
[TBL] [Abstract][Full Text] [Related]
38. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain.
Siljander P; Farndale RW; Feijge MA; Comfurius P; Kos S; Bevers EM; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):618-27. PubMed ID: 11304481
[TBL] [Abstract][Full Text] [Related]
39. The chaperone protein HSP47: a platelet collagen binding protein that contributes to thrombosis and hemostasis.
Sasikumar P; AlOuda KS; Kaiser WJ; Holbrook LM; Kriek N; Unsworth AJ; Bye AP; Sage T; Ushioda R; Nagata K; Farndale RW; Gibbins JM
J Thromb Haemost; 2018 May; 16(5):946-959. PubMed ID: 29512284
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression.
Ohlmann P; Hechler B; Ravanat C; Loyau S; Herrenschmidt N; Wanert F; Jandrot-Perrus M; Gachet C
J Thromb Haemost; 2008 Jun; 6(6):1003-11. PubMed ID: 18419749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
